Skip to main content

WELLS FARGO & COMPANY/MN

Position in LGND — Ligand Pharmaceuticals Inc

CIK 72971 SAN FRANCISCO, CA

Position in LGND

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$16,950,483
-$8,127,003 QoQ
Shares Held
84,901
-36.0% QoQ
Ownership
0.424%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.91637318759497.ToString("F0")% Shared 0.ToString("F0")% None 0.08362681240503646.ToString("F0")%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. LGND ranks #11 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LGND

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $16,950,483 84,901
2025-12-31 $25,077,486 132,636
2025-09-30 $20,402,451 115,177
2025-06-30 $1,505,235 13,241
2025-03-31 $1,346,317 12,805
2024-12-31 $1,202,222 11,220
2024-09-30 $865,778 8,650
2024-06-30 $742,414 8,811
2024-03-31 $500,733 6,850
2023-12-31 $405,664 5,680
2023-09-30 $270,297 4,511
2023-06-30 $566,920 7,863
2023-03-31 $304,683 4,142
2022-12-31 $133,732 2,002
2022-09-30 $143,155 2,665
2022-06-30 $161,463 2,901
2022-03-31 $1,523,140 21,705
2021-12-31 $3,581,580 37,170
2021-09-30 $3,826,038 44,022
2021-06-30 $2,966,054 36,242
2021-03-31 $3,945,151 41,483
2020-12-31 $2,185,601 35,229
2020-09-30 $3,237,607 54,447
2020-06-30 $5,205,172 74,599
2020-03-31 $4,253,955 93,772